Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Multiple myeloma treatment strategies with novel agents in 2011: A European perspective
Oncologist, Volume 16, No. 4, Year 2011
Notification
URL copied to clipboard!
Description
The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with data to make evidence-based decisions regarding the optimal management of patients. This review is an update to a previous summary of European treatment practices that examines new data that have been published or presented at congresses up to the end of 2010 and assesses their impact on treatment practices. © AlphaMed Press.
Authors & Co-Authors
Ludwig, Heinz P.
Austria, Vienna
Wiener Krankenanstaltenverbund
Beksac, M. S.
Turkey, Ankara
Ankara Üniversitesi
Bladé, Joan
Spain, Barcelona
Hospital Clinic Barcelona
Cavenagh, Jamie
United Kingdom, London
St Bartholomew's Hospital
Cavo, Michele
Italy, Bologna
Institute 'seragnoli'
Delforge, Michel
Belgium, Leuven
Ku Leuven– University Hospital Leuven
Dimopoulos, Meletios A.
Greece, Athens
School of Medicine
Drach, Johannes W.
Austria, Vienna
University Clinic of Vienna
EINSELE, HERMANN
Germany, Wurzburg
Universitätsklinikum Würzburg
Façon, Thierry
France, Lille
Chu Lille
Göldschmidt, Hartmut M.
Germany, Heidelberg
Universität Heidelberg
Harousseau, Jean Luc
France, Saint-herblain
Clcc Nantes Atlantique Centre René gauducheau
Heß, Ursula
Switzerland, St Gallen
Kantonsspital st Gallen, Division of Oncology-haematology
Kropff, Martin
Germany, Munster
University of Münster
da Costa, Fernando Leal
Portugal, Lisbon
Instituto Portugues de Oncologia de Francisco Gentil Lisboa
Louw, Vernon Johan
South Africa, Bloemfontein
University of the Free State
Magen-Nativ, Hila
Israel, Petah Tiqwa
Rabin Medical Center Israel
Mendeleeva, Larisa
Russian Federation, Moscow
National Medical Research Center for Hematology
Nahi, Hareth
Sweden, Stockholm
Karolinska Universitetssjukhuset
Plesner, Torben
Denmark, Odense
Syddansk Universitet
San-Miguel, J. Fernando
Spain, Salamanca
Hospital Clínico Universitario de Salamanca
Sonneveld, Pieter
Netherlands, Rotterdam
Erasmus Mc
Udvardy, Miklós László
Hungary, Debrecen
Általános Orvostudományi Kar
Sondergeld, Pia
United Kingdom, Faringdon
Ammonite Systems Ltd
Palumbo, Antonio
Italy, Turin
Università Degli Studi Di Torino
Statistics
Citations: 38
Authors: 25
Affiliations: 25
Identifiers
Doi:
10.1634/theoncologist.2010-0386
ISSN:
10837159
e-ISSN:
1549490X
Research Areas
Health System And Policy